The Journal of Experimental Medicine · 2010 · 101 citations · 56 references
Life SciencesMolecular BiologyOncologyCell SignalingMolecular OncologySignal TransductionB Cell BiologyCancer Cell SignalingGermline Cancer SusceptibilityImmune Cell SignalingOncogenic Signaling PathwaysSignal Transduction In CancerB Cell Signaling GenesGermline PredispositionImmature B Cell DevelopmentImmunoglobulin ProductionMutationNf-kappa B-dependent TranscriptionNuclear Factor Kappa B SignalingSignaling
The cytokine B cell activating factor (BAFF) and its receptor, BAFF receptor (BAFF-R), modulate signaling cascades critical for B cell development and survival. We identified a novel mutation in TNFRSF13C, the gene encoding human BAFF-R, that is present in both tumor and germline tissue from a subset of patients with non-Hodgkin lymphoma. This mutation encodes a His159Tyr substitution in the cytoplasmic tail of BAFF-R adjacent to the TRAF3 binding motif. Signaling through this mutant BAFF-R results in increased NF-κB1 and NF-κB2 activity and increased immunoglobulin production compared with the wild-type (WT) BAFF-R. This correlates with increased TRAF2, TRAF3, and TRAF6 recruitment to His159Tyr BAFF-R. In addition, we document a requirement for TRAF6 in WT BAFF-R signaling. Together, these data identify a novel lymphoma-associated mutation in human BAFF-R that results in NF-κB activation and reveals TRAF6 as a necessary component of normal BAFF-R signaling.
56
Clustal W and Clustal X version 2.0
Mark Larkin, Gordon Blackshields, Nigel P. Brown et al. · Bioinformatics · 2007 · 29.1K citations · Full text
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
R. Eric Davis, Vu N. Ngo, Georg Lenz et al. · Nature · 2010 · 1.6K citations · Full text
Medicine, Hematology, Oncology +14
TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease
Jane A. Gross, Janet Johnston, Sherri Mudri et al. · Nature · 2000 · 1.2K citations